Niimura M
Gan To Kagaku Ryoho. 1984 Feb;11(2):221-6.
In the dermatological field, interferon is used in clinical trials for viral skin diseases and for malignant skin tumors such as malignant melanoma. In regard to viral diseases, clinical trials have shown promising results in viral warts, herpes simplex and herpes zoster. In the double-blind trial, patients with bilateral common warts of the extremities were treated at weekly intervals with intralesional injections of either human fibroblast interferon or placebo. More than 81% of the interferon-treated extremities were either cured by or responded effectively to the therapy, while only 17% of the placebo responded. Although our data has confirmed that interferon is effective in the treatment of common warts diseases, the method of application and repeated injections indicate that this therapy may not be helpful in routine cases but only in selected patients in whom other therapy has failed. However, development of new delivery systems or modification of dosages may increase the value of interferon therapy for warts disease. Interferon seems also effective for herpes zoster. But herpes zoster usually regresses spontaneously within three weeks, therefore, it is not easy to define efficacy of interferon in this disease. Therefore, we need to examine the effect of interferon on herpes zoster both in placebo controlled and double-blind trials involving patients with immunocompromised diseases.
在皮肤科领域,干扰素被用于病毒性皮肤病和恶性皮肤肿瘤(如恶性黑色素瘤)的临床试验。关于病毒性疾病,临床试验已在病毒疣、单纯疱疹和带状疱疹方面显示出有前景的结果。在双盲试验中,对四肢双侧寻常疣患者每隔一周进行皮损内注射人成纤维细胞干扰素或安慰剂治疗。接受干扰素治疗的四肢中超过81% 要么治愈,要么对治疗有有效反应,而接受安慰剂治疗的仅有17% 有反应。虽然我们的数据已证实干扰素在治疗寻常疣疾病方面有效,但应用方法和重复注射表明这种疗法可能对常规病例无帮助,而仅对其他治疗失败的特定患者有用。然而,新给药系统的开发或剂量调整可能会增加干扰素治疗疣病的价值。干扰素似乎对带状疱疹也有效。但带状疱疹通常在三周内自行消退,因此,很难确定干扰素在这种疾病中的疗效。所以,我们需要在涉及免疫功能低下疾病患者的安慰剂对照和双盲试验中研究干扰素对带状疱疹的作用。